Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the amount of Streptococcus mutans in saliva: a randomized clinical trial
The aim of this study was to evaluate the effect of short-term use of probiotics containing Streptococcus salivarius K12 and M18 bacteria on salivary Streptococcus mutans in order to evaluate their effectiveness in reducing tooth decay.
Design
A randomized controlled clinical trial with a parallel group design of 40 patients. Block method and random allocation software were used for randomization.
Settings and conduct
The place of sampling and examination of people is in the School of Dentistry of Isfahan University of Medical Sciences. Saliva samples are taken from individuals before and after the intervention and cultured, and bacterial colonies are counted.
Participants/Inclusion and exclusion criteria
Entry requirements: people without orthodontic appliques or six months after the end of orthodontic treatment; people who have not taken antibiotics in the past month; people who do not have incomplete dental treatment; people without immune system diseases.
No entry conditions: people with orthodontic appliques or people who have had orthodontic treatment for less than six months; people who have taken antibiotics in the past month; people undergoing incomplete dental treatment; people with immune system diseases.
Intervention groups
Probiotic products containing Salivarius M18 and K12 are claimed to be useful in preventing dental caries, however, little research is available to conclusively prove this. This study was designed to evaluate the efficacy of these probiotic substances. The control group in this study also took oral deodorant tablets with the same taste and consistency as the intervention group tablets.
Main outcome variables
The amount of Streptococcus mutans in saliva; the plaque index of individuals
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20210811052147N1
Registration date:2021-10-17, 1400/07/25
Registration timing:prospective
Last update:2021-10-17, 1400/07/25
Update count:0
Registration date
2021-10-17, 1400/07/25
Registrant information
Name
Mohammad reza esrafili bishe
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3663 1299
Email address
esrafili77@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-10-20, 1400/07/28
Expected recruitment end date
2021-11-19, 1400/08/28
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the amount of Streptococcus mutans in saliva: a randomized clinical trial
Public title
Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the amount of Streptococcus mutans in saliva: a randomized clinical trial
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
People without orthodontics or people who have had orthodontic treatment for more than six months
People who have not taken antibiotics in the past month
People who do not have incomplete dental treatment
People without immune system diseases
Exclusion criteria:
People with orthodontic appliques or people who have had orthodontic treatment for less than six months
People who have taken antibiotics in the past month
People undergoing incomplete dental treatment
People with immune system diseases
Age
From 19 years old to 35 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
Individuals are randomly divided into 2 groups of 20 people. In order to maintain the equality of the number of people in both groups, in this study, the limited randomization method of block randomization will be used. Blocking is usually used to balance the number of samples assigned to each of the study groups. This feature helps researchers to equate the number of samples assigned to each of the study groups in cases where intermediate analyzes are required during the sampling process. The size of all the blocks is the same and in this two-group experiment we will have 40 blocks of 20 people including 20 people in the probiotic group and 20 people in the control group (mouth freshener pill).The randomization tool will be the latest version of random allocation software, which in addition to simple randomization will also be able to block randomization. We also use allocation concealment, which is the method used to execute random sequences on study participants so that the assigned group is not known before the individual is assigned. Using opaque envelopes sealed with random sequence (Sequentially numbered, sealed, opaque envelopes) in which in this method each random sequence is recorded on a card and the cards are inside the envelopes respectively. Are placed. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lids of the letter envelopes are glued and placed inside a box, respectively. At the beginning of the registration of participants, based on the order of entry of eligible participants into the study, one of the envelopes of the letter is opened in order and the assigned group of the participant is revealed.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical Sciences, Hezar Jarib Boulevard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Approval date
2021-10-12, 1400/07/20
Ethics committee reference number
IR.MUI.RESEARCH.REC.1400.297
Health conditions studied
1
Description of health condition studied
Dental caries
ICD-10 code
K02
ICD-10 code description
Dental caries
Primary outcomes
1
Description
The amount of Streptococcus mutans in saliva
Timepoint
Saliva samples are collected at the beginning and end of the intervention.
Method of measurement
Bacteria are measured based on colony count
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period. Individuals take a tablet containing the probiotic bacteria Streptococcus salivarius M18 and K12 in their mouth every night before going to bed and suck it until it dissolves and consume this substance for 20 days. This tablet is under the brand name of Lactogam and is a product of Zist Takhmir Company and is made in Iran. These tablets contain 150 mg of M18 bacteria and 150 mg of K12 bacteria. Also, more than 10 to the power of 9 colonies of these bacteria are present in each tablet. The taste of this pill is mint.
Category
Prevention
2
Description
Control group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period. Individuals put a mouthwash pill in their mouth at night before going to bed and suck it until it dissolves and consume this substance for 20 days. This pill is under the brand name of Iceberg and made in Iran in Shiva food industry. The sweetener in this pill is xylitol and it is unusable for bacteria in the mouth. Also, the dose of xylitol in each deodorant pill is extremely low and has no therapeutic effect of xylitol. The taste of this pill is mint.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
School of Dentistry of University of Medical Sciences of Isfahan
Full name of responsible person
Firoozeh Nilchian
Street address
School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3792 5594
Email
f_nilchian@dnt.mui.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Shaghayegh Haghjooy Javanmard
Street address
Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8138
Email
sh_haghjoo@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Firoozeh Nilchian
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3792 5594
Email
f_nilchian@dnt.mui.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Firoozeh Nilchian
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3792 5594
Email
f_nilchian@dnt.mui.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Firoozeh Nilchian
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3792 5594
Email
f_nilchian@dnt.mui.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
All our data except people names and phone numbers can be published
When the data will become available and for how long
The data will be available 1 year after the results are published.
To whom data/document is available
The data is accessible to academic researchers and industry researchers. It should be noted that this information will be available only to Iranian universities and companies.
Under which criteria data/document could be used
If the data is not deleted and changed and the purpose of using the data is clear to the early researchers, it is possible to use the data at the discretion of the early researchers. It should be noted that in case of any discrepancy with moral principles or having bad intentions, this information will not be provided to individuals.
From where data/document is obtainable
Dr. Firoozeh Nilchian
Address: School of Dentistry, Isfahan University of Medical Sciences
Phone: 00983137925594
Email: f_nilchian@dnt.mui.ac.ir
Postal Code: 8174673461
What processes are involved for a request to access data/document
The application must be mentioned by phone number or email. Then, if the initial researchers agree, the necessary information will be provided to the applicants as soon as possible.